— Know what they know.
Not Investment Advice

PMI AMEX

Picard Medical, Inc.
1W: +21.9% 1M: +22.9% 3M: +3117.1% YTD: +209.3% 1Y: -36.3%
$5.78
+1.46 (+33.80%)
 
Weekly Expected Move ±25.0%
$3 $4 $6 $7 $8
AMEX · Healthcare · Medical - Devices · Tech Score Neutral · Power 44 · $11.9M mcap · 1M float · 129.23% daily turnover · Short 29% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
46.2 / 100
NoneWeakNarrowWide
Primary source: Switching Costs  ·  ROIC: -469.0%
Cost Advantage
38
Intangibles
40
Switching Cost
70
Network Effect
39
Scale
35
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PMI shows a Weak competitive edge (46.2/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Switching Costs. Negative ROIC of -469.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
Analyst Recommendations
Strong Buy: 0Buy: 0Hold: 1Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$—
Analysts0
Consensus Change History
DateFieldFromTo
2026-06-05 consensus Buy Hold

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 02, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PMI receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-20 C D+
2026-08-03 None ADDED
2026-07-28 EXISTED None
2026-05-15 D+ C
2026-03-26 C- D+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 22 Grade D
Profitability
6
Balance Sheet
21
Earnings Quality
33
Growth
—
Value
34
Momentum
—
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PMI scores highest in Value (34/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-21.88
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✗ ✗ ✓ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
8.81
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 18.6/100
Earnings Quality
—
OCF/NI: 0.57x
Accruals: -130.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PMI scores -21.88, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PMI scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PMI's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PMI receives an estimated rating of CCC (score: 18.6/100).

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.28x
PEG
0.04x
P/S
1.89x
P/B
6.25x
P/FCF
-0.02x
P/OCF
—
EV/EBITDA
-0.05x
EV/Revenue
0.18x
EV/EBIT
-0.05x
EV/FCF
-0.07x
Earnings Yield
-9225.00%
FCF Yield
-5295.86%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PMI currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.999
NI / EBT
×
Interest Burden
1.140
EBT / EBIT
×
EBIT Margin
-3.902
EBIT / Rev
×
Asset Turnover
0.687
Rev / Assets
×
Equity Multiplier
5.342
Assets / Equity
=
ROE
-1631.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PMI's ROE of -1631.2% is driven by financial leverage (equity multiplier: 5.34x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 275 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$5.63
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.74
Ann. Volatility
423.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Patrick NJ Schnegelsberg,
Former Chief Executive Officer
$400,000 $— $400,000
Matt Schuster, Operating
rating Officer
$220,000 $— $220,000
Bernard Skaggs, Financial
ief Financial Officer
$200,000 $— $200,000

CEO Pay Ratio

3:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $400,000
Avg Employee Cost (SGA/emp): $133,333
Employees: 75

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
75
Revenue / Employee
$65,867
Rev: $4,940,000
Profit / Employee
$-360,000
NI: $-27,000,000
SGA / Employee
$133,333
Avg labor cost proxy
R&D / Employee
$40,000
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -1.3% -3.9% 15.4% -16.3% -16.31%
ROA -77.1% -65.3% -2.0% -3.1% -3.05%
ROIC -46.6% -2.1% -4.9% -4.7% -4.69%
ROCE -98.5% -3.2% 13.9% -14.3% -14.33%
Gross Margin -11.0% 80.8% 23.9% 20.9% 20.85%
Operating Margin -2.9% -2.5% -3.9% -1.6% -1.57%
Net Margin -8.8% -4.3% -6.6% -1.9% -1.92%
EBITDA Margin -6.7% -4.2% -6.5% -1.5% -1.52%
FCF Margin -5.5% -5.0% -4.4% -2.6% -2.55%
OCF Margin -5.5% -5.0% -4.4% -2.5% -2.55%
ROIC Economic snapshot only -4.69%
Cash ROA snapshot only -1.75%
Cash ROIC snapshot only -6.28%
CROIC snapshot only -6.29%
NOPAT Margin snapshot only -1.90%
Pretax Margin snapshot only -4.45%
R&D / Revenue snapshot only 74.89%
SGA / Revenue snapshot only 1.91%
SBC / Revenue snapshot only 31.35%
Valuation
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -44.39 -8.76 -0.07 -0.01 -0.283
P/S Ratio 389.93 58.73 0.46 0.05 1.890
P/B Ratio 58.09 34.04 -1.07 0.18 6.251
P/FCF -71.05 -11.84 -0.11 -0.02 -0.019
P/OCF — — — — —
EV/EBITDA -58.36 -10.55 -0.24 -0.05 -0.048
EV/Revenue 388.19 58.05 1.41 0.18 0.181
EV/EBIT -57.44 -10.33 -0.24 -0.05 -0.047
EV/FCF -70.74 -11.71 -0.32 -0.07 -0.071
Earnings Yield -2.3% -11.4% -14.4% -92.3% -92.25%
FCF Yield -1.4% -8.4% -9.5% -53.0% -52.96%
PEG Ratio snapshot only 0.041
Price/Tangible Book snapshot only 0.477
EV/Gross Profit snapshot only 0.726
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 2.16 1.11 0.75 1.02 1.019
Quick Ratio 0.94 0.72 0.16 0.22 0.218
Debt/Equity 0.09 1.58 -2.26 0.51 0.512
Net Debt/Equity -0.26 -0.39 — 0.49 0.490
Debt/Assets 0.06 0.26 0.29 0.10 0.096
Debt/EBITDA -0.10 -0.49 -0.17 -0.04 -0.036
Net Debt/EBITDA 0.26 0.12 -0.16 -0.03 -0.035
Interest Coverage -3.34 -5.13 -8.28 -9.84 -9.841
Equity Multiplier 1.70 5.95 -7.75 5.34 5.342
Cash Ratio snapshot only 0.005
Debt Service Coverage snapshot only -9.630
Cash to Debt snapshot only 0.043
FCF to Debt snapshot only -18.302
Defensive Interval snapshot only 14.2 days
Efficiency & Turnover
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.09 0.10 0.30 0.69 0.687
Inventory Turnover 0.20 0.21 0.32 0.79 0.791
Receivables Turnover 1.33 3.52 5.61 10.26 10.261
Payables Turnover 0.42 0.73 0.88 1.42 1.422
DSO 274 104 65 36 35.6 days
DIO 1816 1764 1139 461 461.3 days
DPO 865 502 415 257 256.8 days
Cash Conversion Cycle 1225 1365 789 240 240.1 days
Fixed Asset Turnover snapshot only 12.727
Operating Cycle snapshot only 496.8 days
Cash Velocity snapshot only 165.789
Capital Intensity snapshot only 1.455
Growth Quality
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability — — — — —
Earnings Stability — — — — —
Margin Stability — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0
Earnings Persistence — — — — —
Earnings Smoothness — — — — —
ROE Trend — — — — —
Gross Margin Trend — — — — —
FCF Margin Trend — — — — —
Sustainable Growth Rate — — — — —
Internal Growth Rate — — — — —
Cash Flow Quality
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.62 0.74 0.66 0.57 0.573
FCF/OCF 1.00 1.00 1.00 1.00 1.002
FCF/Net Income snapshot only 0.574
CapEx/Revenue 0.0% 0.0% 0.8% 0.4% 0.41%
CapEx/Depreciation snapshot only 0.049
Accruals Ratio -0.29 -0.17 -0.68 -1.30 -1.303
Sloan Accruals snapshot only 0.050
Cash Flow Adequacy snapshot only -617.038
Dividends & Buybacks
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — —
FCF Payout Ratio — — — — —
Total Payout Ratio — — — — —
Div. Increase Streak — — — — —
Chowder Number — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -3.4% -10.3% -8.6% -53.9% -53.87%
Total Shareholder Return -3.4% -10.3% -8.6% -53.9% -53.87%
DuPont Factors
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 0.999
Interest Burden (EBT/EBIT) 1.30 1.19 1.12 1.14 1.140
EBIT Margin -6.76 -5.62 -5.96 -3.90 -3.902
Asset Turnover 0.09 0.10 0.30 0.69 0.687
Equity Multiplier 1.70 5.95 -7.75 5.34 5.342
Per Share
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-0.19 $-0.20 $-15.00 $-15.08 $-15.08
Book Value/Share $0.15 $0.05 $-0.97 $0.92 $0.92
Tangible Book/Share $0.13 $0.04 $-1.71 $0.34 $0.34
Revenue/Share $0.02 $0.03 $2.25 $3.39 $3.39
FCF/Share $-0.12 $-0.15 $-9.89 $-8.66 $-8.66
OCF/Share $-0.12 $-0.15 $-9.87 $-8.64 $-8.64
Cash/Share $0.05 $0.10 $0.08 $0.02 $0.02
EBITDA/Share $-0.14 $-0.16 $-13.14 $-12.96 $-12.96
Debt/Share $0.01 $0.08 $2.20 $0.47 $0.47
Net Debt/Share $-0.04 $-0.02 $2.12 $0.45 $0.45
Academic Models
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — -21.882
Altman Z-Prime snapshot only -49.925
Piotroski F-Score 2 2 2 2 2
Beneish M-Score — — — — —
Ohlson O-Score snapshot only 8.807
ROIC (Greenblatt) snapshot only -38.65%
Net-Net WC snapshot only $0.08
EVA snapshot only $-12242270.00
Credit
Metric Trend Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only CCC
Credit Score 59.94 17.45 12.92 18.58 18.577
Credit Grade snapshot only 17
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 7
Sector Credit Rank snapshot only 9

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms